Pharmaceuticals

Senestech

Senestech released FY2026 Q1 earnings on May 12 After-Market EST, actual revenue USD 493 K (forecast USD 632 K), actual EPS USD -0.3919 (forecast USD -0.33)

Senestech to Release FY2026 Q1 Earnings on May 12 After-Market EST, Forecast Revenue USD 632 K, EPS USD -0.33

Senestech released FY2025 earnings on March 13 After-Market EST, actual revenue USD 2.221 M (forecast USD 2.576 M), actual EPS USD -1.9484 (forecast USD -2.73)

Senestech released FY2025 Q4 earnings on March 13 After-Market EST, actual revenue USD 421 K (forecast USD 776 K), actual EPS USD -0.3453 (forecast USD -0.3)

Senestech to Release FY2025 Q4 Earnings on March 12 After-Market EST, Forecast Revenue USD 776K, EPS USD -0.3

H.C. Wainwright Analyst Gives SenesTech a Buy Rating

Senestech released FY2025 9 Months Earnings on November 10 After-Market EST, with actual revenue of USD 1.8 M and EPS of USD -2.4302

Senestech released FY2025 Q3 earnings on November 10 After-Market EST, actual revenue USD 690K (forecast USD 730K), actual EPS USD -0.28 (forecast USD -0.35)

Senestech to Release FY2025 Q3 Earnings on November 10 After-Market EST, Forecast Revenue USD 730K, EPS USD -0.35

Senestech released FY2025 Semi-Annual earnings on August 8 After-Market (EST), actual revenue USD 1.11 M, actual EPS USD -2.0781

Senestech released FY2025 Q2 earnings on August 7 After-Market EST, actual revenue USD 625K (forecast USD 625K), actual EPS USD -0.8713

Senestech to Release FY2025 Q2 Earnings on August 7 After-Market EST

SenesTech Inc. Exercises Warrants to Raise $4.4 Million

SenesTech Expands Evolve Rat Fertility Control Product in Baltimore

SenesTech Expands Rural Market Penetration in the US

SenesTech Holds Annual Meeting to Elect Directors

Senestech released FY2025 Q1 earnings on May 8 After-Market EST, actual revenue USD 485K, actual EPS USD -1.2807

SenesTech Signs Exclusive Distribution Agreement with Asa Jaya Mandiri to Promote Rodent Control Soft Bait in Indonesia

Senestech to Release FY2025 Q1 Earnings on May 8 After-Market EST

SenesTech, Inc. deploys mouse birth control in Chicago

Netcapital

Agape ATP

Tradr 2X Long QBTS Daily ETF

Akanda

Defiance Daily Target 2X Long RGTI ETF

PicoCELA

Tradr 2X Long RGTI Daily ETF

Co-Diagnostics

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NewGenIvf

SNES

SenesTech to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 | SNES Stock News

StockTitan

SenesTech to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 | SNES Stock News

Earnings Watch

Senestech | 10-Q: FY2026 Q1 Revenue Misses Estimate at USD 493 K

LABU

SBIO

SenesTech (NASDAQ:SNES) reported a 2% year-over-year increase in Q1 2026 revenue to $493,000, driven by a 42% rise in direct-to-consumer sales. Subscription revenue grew by 44%, indicating a shift towards a recurring revenue model. The gross margin improved to 68.6%. The company is focusing on enhancing direct-to-consumer sales, restructuring B2B processes, and pursuing selective international expansion. Management plans to optimize operating expenses and explore new rodent control products under the Evolve brand. This earnings call marks the first for newly appointed CEO Michael Edel, who emphasizes scaling the business effectively.

benzinga_article

iShares Biotechnology ETF

Direxion S&P Biotech Bull 3X

Invesco Biotechnology & Genome ETF

VanEck Biotech ETF

ALPS Medical Breakthrough

First Trust NYSE Arca Biotech Index Fd

SPDR S&P Biotech

Amazon

SenesTech Q1 2026 Earnings Call: Complete Transcript

Senestech | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 493 K

FORM

Formfactor pre-market up 10.91%; Senestech pre-market down 8.58%; Odysight.ai pre-market up 110.99%; Jiuzi pre-market up 55.80%; Click Holdings/BVI pre-market up 49.78%

Price Alert

Formfactor

Odysight.ai

Jiuzi

Click Holdings/BVI

Hot pre-market trades in US stocks: Formfactor up 10.91% in pre-market; Senestech down 8.58% in pre-market

SenesTech, Inc. (NASDAQ: SNES) will report its first quarter 2026 financial results on May 12, 2026, after market close. A conference call is scheduled for the same day at 5:00 p.m. ET to discuss the results. The company focuses on fertility control for managing animal pest populations and offers EPA-compliant Rodent Birth Control™ products. Interested parties can access the call via a live webcast, with a replay available for 90 days. Forward-looking statements are included, subject to risks and uncertainties.

prnewswire

Proshares Ultra Nasdaq Biotech

16:30 ETSenesTech to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026

SenesTech, Inc. has appointed Michael Edell as President and CEO, effective May 6, 2026, to enhance revenue growth and operational execution. Edell, who has a strong background in consumer product businesses and e-commerce, aims to focus on direct-to-consumer channels and expand B2B opportunities. The leadership transition also includes updates to the Board, with Matthew Szot becoming Board Chair. SenesTech is committed to improving pest management through innovative, humane solutions, and aims to strengthen its market presence and revenue channels.

08:30 ETSenesTech Appoints Michael Edell as President and Chief Executive Officer to Drive Revenue Growth and Scalable Sales Channels

Senestech(SNES.US)

SenesTech to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 | SNES Stock News

Senestech | 10-Q: FY2026 Q1 Revenue Misses Estimate at USD 493 K

SenesTech Q1 2026 Earnings Call: Complete Transcript

Senestech | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 493 K

Hot pre-market trades in US stocks: Formfactor up 10.91% in pre-market; Senestech down 8.58% in pre-market

16:30 ETSenesTech to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026

08:30 ETSenesTech Appoints Michael Edell as President and Chief Executive Officer to Drive Revenue Growth and Scalable Sales Channels